Meng Zhuang

Meng Zhuang

Auto-generated profile, based on publicly available information

Meng Zhuang

Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in EBioMedicine
Verified
Journal Article
Open access
MZMeng Zhuang
Meng Zhuang
SZSenlin Zhao
Senlin Zhao
ZJZheng Jiang
Zheng Jiang
SWSong Wang
Song Wang
PSPeng Sun
Peng Sun
XWXishan Wang
Xishan Wang
The low expression of miR93/25 (members of miR-106b~25 cluster) promoted the invasion and metastasis of colon cancer cells, which predicted poor survival. However, the role of miR-106b-5p, the member of miR-106b~25 cluster, in colorectal cancer (CRC) remains unclear. Bioinformatics methods were used to predict the potential pairs of lncRNA-miRNA-mRNA. In situ hybridization and qPCR were used to evaluate the expression of MALAT1 and miR-106b-5p in the paraffin-embedded normal and CRC tissues. Kaplan-Meier analysis with the log-rank test was used for survival analyses. Immunohistochemistry staining was applied to investigate the expression of SLAIN2. Fluorescence recovery after photobleaching assay was applied to observe the microtubule (MT) mobility. In vitro and in vivo invasion and metastasis assays were used to explore the function of MALAT1/miR-106b-5p/SLAIN2 in the progression of CRC. miR-106b-5p was identified as a suppressor in CRC. Functionally, ectopic or silencing the expression of miR-106b-5p inhibited or promoted the invasion and metastasis of CRC cells in vitro and in vivo. The long non-coding RNA MALAT1 regulated the miR-106b-5p expression and further mediated the mobility of SLAIN2-related MTs by functioning as a competing endogenous RNA in vitro and in vivo, which resulted in the progression of CRC. Clinically, low miR-106b-5p expression predicted poor survival of CRC patients, especially in combination with high MALAT1/ SLAIN2 expression. miR-106b-5p served as a suppressor in combination with MALAT1/miR-106b-5p/SLAIN2, which might be a group of potential prognostic biomarkers in the prognosis of CRC. FUND: This work was supported by National Program Project for Precision Medicine in National Research and Development Plan of China (2016YFC0905300), National Natural Science Foundation of China (81572930), National Key Research and Development Program of the Ministry of Science and Technology of China (2016YFC0905303, 2016YFC1303200), Beijing Science and Technology Program (D17110002617004), Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2018PT32012), CAMS Innovation Fund for Medical Sciences (CIFMS) (2016-I2M-1-001), Incentive Fund for Academic Leaders of Oncology Hospital, Chinese Academy of Medical Sciences (RC2016003), and Beijing Hope Run Special Fund from Cancer Foundation of China (LC2017A19). The project of Shanghai Jiaotong Univversity (YG2017QN30).

18 November 2024 in Oncogene
Verified
Journal Article
Closed access
PDF file
MZMeng Zhuang
Meng Zhuang
JLJialiang Liu
Jialiang Liu
YLYuegang Li
Yuegang Li
JZJinzhu Zhang
Jinzhu Zhang
ZJZheng Jiang
Zheng Jiang
JTJianqiang Tang
Jianqiang Tang

9 May 2024 in Research Square
Verified
Preprint
Open access
PDF file
XWXi-Shan Wang
Xi-Shan Wang
MZMeng Zhuang
Meng Zhuang
TCTianli Chen
Tianli Chen
JLJialiang Liu
Jialiang Liu
JLJiangfang Lv
Jiangfang Lv
JTJianqiang Tang
Jianqiang Tang
Tumor infiltrating lymphocytes largely determined tumorigenesis and progression. We found PD-L1 can inhibit the infiltration of memory T cells in vivo and in vitro by reducing the secretion of CXCL9,CXCL10 in colorectal cancer. Clinically, patients with high PD-L1 expression had few memory T cells infiltration, resulting in a higher incidence of tumor metastasis. Furthermore, single-cell sequencing revealed that PD-L1 mainly inhibited the tissue infiltration of a specific Tm cell subset characterized by the expression of FGFBP2 gene. To clarify the distribution of FGFBP2(+)Tm cells, peripheral blood, lymph nodes, colon polyps, primary tumor, and liver metastases samples were collected. As the tumor progressed, the infiltration of FGFBP2(+) memory T cells gradually increased and accumulated in liver metastases. FGFBP2(+) memory T cells were closely correlated with the distribution of CD31 and positively correlated with the neovascularization density and metastatic nodules. By comparing the transcriptome differences between metastatic and non-metastatic lymph nodes, it was revealed that the expression of FGFBP2 and FGF19 were significantly increased in metastatic lymph nodes. Mechanistically, FGF19, the binding factor of FGFBP2 can induce inflammatory cancer-associated fibroblasts resulting in liver metastasis. Therefore, the elevated FGFBP2(+) memory T cells can promote liver metastasis in colorectal cancer. One Sentence Summary: PD-L1 can inhibit the infiltration of memory T cells, and increased FGFBP2(+)Tm cells can promote tumor metastasis